Imaging Biometrics Ltd.
Research Imaging Biometrics Ltd. (IBAI.L) on Bullrun: market cap GBX 246.71M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIBAI.L
- ExchangeLSE
- CountryJersey
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyGBX
- Market capGBX 246.71M
- Financial periodFY2025
- RevenueGBP 788.15K
- Revenue growth5.1%
- Net income-GBP 400.94K
- Free cash flow-GBP 190.06K
- Gross margin93.5%
Valuation Snapshot
latest market cap is GBX 246.71M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 788.15K | -GBP 400.94K | -GBP 190.06K | 93.5% | 0 | GBP 112.61K | n/a | GBP 407.62K |
| FY2024 | GBP 750.11K | -GBP 327.10K | -GBP 445.14K | 99.0% | 0 | GBP 53.50K | n/a | GBP 302.53K |
| FY2023 | GBP 609.39K | -GBP 623.82K | -GBP 175.23K | 98.1% | 0 | GBP 138.75K | GBP 0 | GBP 94.92K |
| FY2022 | GBP 535.89K | -GBP 511.60K | -GBP 414.60K | 99.7% | 0 | GBP 313.99K | GBP 0 | GBP 707.07K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | GBX 246.71M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About Imaging Biometrics Ltd.
Imaging Biometrics Ltd. provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, the European Union, South America, Australia, and the United States. It operates through Holding Company, Medical Software, Oral Gallium Maltolate (GaM), and Organ-on-a-Chip segments. The company develops ready-to-use software applications comprising IB Neuro, an MRI perfusion platform that generates quantitative relative cerebral blood volume maps;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Imaging Biometrics Ltd.'s market cap?
Imaging Biometrics Ltd.'s market capitalization is GBX 246.71M.
What does Imaging Biometrics Ltd. do?
Imaging Biometrics Ltd. provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, the European Union, South America, Australia, and the United States. It operates through Holding Company, Medical Software, Oral Gallium Maltolate (GaM), and Organ-on-a-Chip segments.